James E. Flynn, 10% Owner at Homology Medicines, Inc. (FIXX), sold 164,730 shares at $21.68 ($3.6M) on 2019-12-19, disclosed to the SEC on 2019-12-23.
Open-market sale of $3.6M FIXX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.68 | 5,454 | $118K | 3.3% |
| 2 | $21.68 | 7,168 | $155K | 4.3% |
| 3 | $21.50 | 9,130 | $196K | 5.5% |
| 4 | $21.50 | 11,999 | $258K | 7.2% |
| 5 | $21.83 | 56,595 | $1.2M | 34.4% |
| 6 | $21.83 | 74,384 |
| $1.6M |
| 45.3% |
| Total | $21.78 avg | 164,730 | $3.6M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |